Angela V. WEST

Person

Franklin, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heteroaryl compounds for kinase inhibition
- Patent number 11,958,850
- Issue date Apr 16, 2024
- Takeda Pharmaceutical Company Limited
- Wei-Sheng Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30...
- Patent number 11,814,386
- Issue date Nov 14, 2023
- Forma Therapeutics, Inc.
- Alex J. Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
- Patent number 11,787,803
- Issue date Oct 17, 2023
- Forma Therapeutics, Inc.
- Shawn E. R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30...
- Patent number 11,535,618
- Issue date Dec 27, 2022
- Forma Therapeutics, Inc.
- Alex J. Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
- Patent number 11,292,791
- Issue date Apr 5, 2022
- Forma Therapeutics, Inc.
- Shawn E. R. Schiller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibiting CREB binding protein (CBP)
- Patent number 11,254,674
- Issue date Feb 22, 2022
- Forma Therapeutics, Inc.
- Shawn E. R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibiting CREB binding protein (CBP)
- Patent number 10,870,648
- Issue date Dec 22, 2020
- Forma Therapeutics, Inc.
- Shawn E. R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds for kinase inhibition
- Patent number 10,227,342
- Issue date Mar 12, 2019
- Ariad Pharmaceuticals, Inc.
- Wei-Sheng Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds for kinase inhibition
- Patent number 9,796,712
- Issue date Oct 24, 2017
- Ariad Pharmaceuticals, Inc.
- Wei-Sheng Huang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS
- Publication number 20240150349
- Publication date May 9, 2024
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30...
- Publication number 20240132499
- Publication date Apr 25, 2024
- Forma Therapeutics, Inc.
- Alex J. Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30...
- Publication number 20230126252
- Publication date Apr 27, 2023
- Forma Therapeutics, Inc.
- Alex J. Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaryl Compounds For Kinase Inhibition
- Publication number 20230102829
- Publication date Mar 30, 2023
- Takeda Pharmaceutical Company Limited
- WEI-SHENG HUANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CBL-B MODULATORS AND USES THEREOF
- Publication number 20230086064
- Publication date Mar 23, 2023
- Nimbus Clio, Inc.
- Silvana Marcel LEIT DE MORADEI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CTPS1 INHIBITORS AND USES THEREOF
- Publication number 20230077316
- Publication date Mar 9, 2023
- Nimbus Clotho, Inc.
- Kevin D. KREUTTER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN (CREB)
- Publication number 20220213089
- Publication date Jul 7, 2022
- Forma Therapeutics, Inc.
- Shawn E.R. SCHILLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS
- Publication number 20220169647
- Publication date Jun 2, 2022
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITING CREB BINDING PROTEIN (CBP)
- Publication number 20220162207
- Publication date May 26, 2022
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30...
- Publication number 20210355126
- Publication date Nov 18, 2021
- Forma Therapeutics, Inc.
- Alex J. Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING CREB BINDING PROTEIN (CBP)
- Publication number 20200299295
- Publication date Sep 24, 2020
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS
- Publication number 20200216445
- Publication date Jul 9, 2020
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING CREB BINDING PROTEIN (CBP)
- Publication number 20200002332
- Publication date Jan 2, 2020
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS FOR KINASE INHIBITION
- Publication number 20190218212
- Publication date Jul 18, 2019
- ARIAD Pharmaceuticals, Inc.
- Wei-Sheng Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS FOR KINASE INHIBITION
- Publication number 20170253594
- Publication date Sep 7, 2017
- ARIAD Pharmaceuticals, Inc.
- Wei-Sheng Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS FOR KINASE INHIBITION
- Publication number 20170197962
- Publication date Jul 13, 2017
- ARIAD Pharmaceuticals, Inc.
- Wei-Sheng HUANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS FOR KINASE INHIBITION
- Publication number 20170166598
- Publication date Jun 15, 2017
- ARIAD Pharmaceuticals, Inc.
- Wei-Sheng HUANG
- C07 - ORGANIC CHEMISTRY

Angela V. WEST

Person

Patents Grantslast 30 patents

Heteroaryl compounds for kinase inhibition

Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30...

Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors

Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30...

Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors

Inhibiting CREB binding protein (CBP)

Inhibiting CREB binding protein (CBP)

Heteroaryl compounds for kinase inhibition

Heteroaryl compounds for kinase inhibition

Patents Applicationslast 30 patents

TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS

FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30...

FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30...

Heteroaryl Compounds For Kinase Inhibition

CBL-B MODULATORS AND USES THEREOF

CTPS1 INHIBITORS AND USES THEREOF

INHIBITING CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN (CREB)

TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS

INHIBITING CREB BINDING PROTEIN (CBP)

FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30...

INHIBITING CREB BINDING PROTEIN (CBP)

TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS

INHIBITING CREB BINDING PROTEIN (CBP)

HETEROARYL COMPOUNDS FOR KINASE INHIBITION

HETEROARYL COMPOUNDS FOR KINASE INHIBITION

HETEROARYL COMPOUNDS FOR KINASE INHIBITION

HETEROARYL COMPOUNDS FOR KINASE INHIBITION